Application for the funds began on Oct. 5.
The U.S. Department of Health and Human Services (HHS) announced $20 billion in new funding through the Health Resources and Services Administration (HRSA). The funds are intended to help providers on the frontlines of the COVID-19 pandemic.
The application process began on Oct. 5 and will end on Nov. 6. This general Phase 3 general distribution will allow providers who have already received Provider Relief Fund payments to apply, as well as those previously ineligible.
For more information on eligibility and application processes, visit Medical Economics.
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
NAID report shows maternal COVID-19 vaccination protects newborns
April 4th 2024New research led by the National Institute of Allergy and Infectious Diseases reveals sustained antibody levels in infants born to vaccinated mothers, underscoring the importance of maternal vaccination in safeguarding newborns against COVID-19.
Read More